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Abstract. 
 
Subcellular targeting of cAMP-dependent
protein kinase (protein kinase A [PKA]) and of type 1
protein phosphatase (PP1) is believed to enhance the
 
speciﬁcity of these enzymes. We report that in addi-
tion to anchoring PKA, A-kinase anchoring protein
AKAP149 recruits PP1 at the nuclear envelope (NE)
upon somatic nuclear reformation in vitro, and that PP1
targeting to the NE is a prerequisite for assembly of
B-type lamins. AKAP149 is an integral membrane
protein of the endoplasmic reticulum/NE network. The
PP1-binding domain of AKAP149 was identiﬁed as
K
 
153
 
GVLF
 
157
 
. PP1 binds immobilized AKAP149 in
vitro and coprecipitates with AKAP149 from puriﬁed
NE extracts. Afﬁnity isolation of PP1 from solubilized
NEs copuriﬁes AKAP149. Upon reassembly of somatic
nuclei in interphase extract, PP1 is targeted to the NE.
Targeting is inhibited by a peptide containing the PP1-
binding domain of AKAP149, abolished in nuclei as-
 
sembled with membranes immunodepleted of AKAP149,
and restored after reincorporation of AKAP149 into
nuclear membranes. B-type lamins do not assemble
into a lamina when NE targeting of PP1 is abolished,
and is rescued upon recruitment of PP1 to the NE. We
propose that kinase and phosphatase anchoring at the
NE by AKAP149 plays in a role in modulating nuclear
reassembly at the end of mitosis.
Key words: AKAP • mitosis • nuclear envelope •
protein kinase A • protein phosphatase 1
 
Introduction
 
The nuclear envelope (NE)
 
1
 
 is a highly dynamic structure
that reversibly breaks down at mitosis (Collas and Courva-
lin, 2000). The NE consists of a double membrane fenes-
trated by nuclear pores and underlaid by the nuclear lam-
ina. The outer nuclear membrane is continuous with the
ER and shares biochemical and functional properties with
the ER. The inner nuclear membrane harbors specific in-
tegral proteins that provide attachment sites for chromatin
and the lamina (Wilson, 2000; Worman and Courvalin,
 
2000). Intermediate filaments called A/C- and B-type lamins
make up the nuclear lamina. Lamins are believed to medi-
ate interactions between the inner nuclear membrane and
chromatin, participate in DNA replication (Ellis et al.,
1997; Spann et al., 1997), and may provide a structural role
for RNA splicing (Jagatheesan et al., 1999). Disassembly
of the NE at mitosis correlates with phosphorylation of
proteins of the nuclear membranes, nuclear pores, lamina,
and chromatin. In late anaphase, ER-derived membranes
associate with chromatin to reform nuclear membranes
(Chaudhary and Courvalin, 1993) and in telophase, lamins
are dephosphorylated and repolymerize into a lamina (Ot-
taviano and Gerace, 1985).
Protein phosphatase type 1 (PP1) has been identified as
a mitotic lamin B phosphatase (Thompson et al., 1997).
PP1 constitutes a family of Ser/Thr phosphatases highly
conserved among eukaryotes. It consists of a catalytic sub-
unit associated with a regulatory and targeting subunit
(Zolnierowicz and Bollen, 2000). PP1 regulates several
processes in mammalian cells, including maintenance of
the tumor suppressor retinoblastoma (Rb) in an active
form (Ludlow et al., 1993), spliceosome assembly (Mer-
moud et al., 1994), histone H1 dephosphorylation (Paul-
son et al., 1996), and mitosis exit (Fernandez et al., 1992).
The multiplicity of PP1 functions implies that the PP1 iso-
forms achieve specificity through subcellular targeting by
their regulatory subunits (Zolnierowicz and Bollen, 2000).
Activities of type II cAMP-dependent protein kinase
(protein kinase A [PKA]) and A-kinase anchoring pro-
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teins (AKAPs) have been implicated in the regulation of
nuclear and chromosome dynamics at mitosis (Lamb et al.,
1991; Collas et al., 1999; Steen et al., 2000). AKAPs ensure
subcellular targeting of the RII regulatory subunit of PKA
and are believed to enhance specificity of PKA activity
(for review see Colledge and Scott, 1999). Few AKAPs
associated with nuclear compartments have been identi-
fied. The developmentally regulated nAKAP150 has been
identified in the nuclear matrix of precartilage nuclei
(Zhang et al., 1996). Another nuclear matrix–associated
AKAP, AKAP95 (Eide et al., 1998), has been shown to
bind chromosomes at mitosis and to be implicated in chro-
mosome condensation (Collas et al., 1999). Finally, a 255-kD
membrane-bound AKAP has been shown to target PKA
to the NE of differentiated myocytes (Kapiloff et al.,
1999). Whether the NE harbors other AKAPs and the sig-
nificance of such associations have not been investigated.
S-AKAP84 (Lin et al., 1995), D-AKAP1 (Huang et al.,
1997), AKAP121 (Chen et al., 1997), and AKAP149
(Trendelenburg et al., 1996) represent AKAP isoforms
that arose by alternative splicing. These isoforms share a
525–amino acid NH
 
2
 
-terminal core but differ in their
COOH-terminal domain. S-AKAP84, D-AKAP1, and
AKAP149 have been shown or suggested to be targeted to
mitochondria. However, two alternative NH
 
2
 
-terminal
splice variants of D-AKAP1 direct this AKAP to mito-
chondria or to the ER (Huang et al., 1999). Moreover, in
assessing PKA-binding proteins of the NE, we have identi-
fied in a PKA-RII overlay assay an 
 
z
 
150-kD AKAP in
purified NE extracts from HeLa cells, which reacted with
anti-AKAP149 mAbs (see Fig. 1 A). This suggested that
AKAP149 is not restricted to mitochondria but might also
be targeted to the ER/NE network.
Using cell fractionation studies, membrane vesicle re-
constitutions, a novel in vitro nuclear reassembly assay,
and competition experiments, we demonstrate here that
AKAP149 is an integral protein of the ER/NE membrane
network. At the NE, AKAP149 recruits PP1 upon nuclear
reassembly in vitro. PP1 anchoring at the NE correlates
with assembly of B-type lamins. These findings support a
model in which AKAP149 anchors a protein phosphatase
implicated in NE reassembly at the end of mitosis.
 
Materials and Methods
 
Antibodies
 
Anti-AKAP149 mAbs raised against amino acids 66–212 of AKAP149
and anti-AKAP95 mAbs were from Transduction Laboratories. Antibod-
ies against calnexin (goat polyclonal G-20) and against PP1 (rabbit poly-
clonal FL-18, and mAb E-19) were from Santa Cruz Biotechnology, Inc.
The anti-PP1 mAb was specific for all PP1 catalytic subunits. Affinity-
purified rabbit antibodies against human lamin B receptor (LBR) and
against a peptide of human lamin B (gifts from B. Buendia and J.-C. Cour-
valin, Institut J. Monod, Paris, France) were as described (Chaudhary and
Courvalin, 1993; Buendia and Courvalin, 1997). Note that the anti-lamin
B antibody did not distinguish between the different human lamin B iso-
forms (these are referred to as lamin B in the text).
 
Cells, Nuclei, and Nuclear Fractionation
 
HeLa cells were grown and synchronized in M phase with nocodazole as
described previously (Eide et al., 1998). Interphase nuclei were isolated
from unsynchronized HeLa cells by Dounce homogenization and sedi-
mentation as described elsewhere (Collas et al., 1999).
High salt–extracted nuclear matrices were prepared as described else-
where (Steen et al., 2000). Nuclear matrices were defined as nuclear scaf-
folds resistant to extraction with 1 mg/ml DNase I, 0.5% Triton X-100,
and 2 M NaCl. Isolation of interphase chromatin was carried out as de-
scribed previously (Collas et al., 1999). Permeabilized nuclei were di-
gested with 5 U micrococcal nuclease, sedimented, the supernatant was
collected, and the pellet was incubated in 2 mM EDTA. After sedimenta-
tion, the second supernatant was combined with the first to yield a soluble
chromatin fraction. Proteins were precipitated with trichloroacetic acid
and dissolved in SDS sample buffer.
NEs were purified from interphase HeLa cells essentially according to
Dwyer and Blobel (1976) except that only one step of DNase/RNase di-
gestion was performed. NEs prepared under these conditions contained
both nuclear membranes and the lamina.
 
Cell Extracts
 
Mitotic cytosolic extracts were prepared from synchronized mitotic HeLa
cells as described previously (Collas et al., 1999). Cells were washed in ly-
sis buffer, packed, resuspended in 1 vol of lysis buffer, homogenized by
sonication, and centrifuged at 10,000
 
 g
 
 for 10 min. The supernatant was
cleared at 200,000
 
 g
 
 for 2.5 h at 4
 
8
 
C in a Beckman SW55Ti rotor. The clear
supernatant (mitotic cytosol) was collected, aliquoted, and frozen. Inter-
phase extracts were prepared as above from unsynchronized HeLa cells
(95–98% in interphase) except that EDTA was omitted from the lysis
buffer.
 
Membrane Vesicle Isolation and Fractionation
 
Mitotic membrane vesicles were recovered from the 200,000
 
-g
 
 pellet after
mitotic cytosol preparation, washed by resuspension and sedimentation at
100,000 
 
g
 
 for 30 min in membrane wash buffer (MWB: 250 mM sucrose,
50 mM KCl, 2.5 mM MgCl
 
2
 
, 50 mM Hepes, pH 7.5, 1 mM DTT, 1 mM
ATP, and protease inhibitors), frozen in liquid nitrogen, and stored at
 
2
 
80°C. Protein concentration of the vesicle fractions was 10 mg/ml. Vesi-
cles prepared from interphase cells were used in fractionation studies.
Vesicles were isolated from 10,000-
 
g
 
 interphase cell extracts by sedimen-
tation at 200,000
 
 g
 
 onto a 2 M sucrose cushion. Vesicles were collected,
washed, and resuspended in membrane wash buffer containing 2 M su-
crose. Vesicles were fractionated by floatation to density equilibrium into
a 2.0–0.2 M sucrose gradient at 150,000
 
 g
 
 in a Beckman SW28 rotor for
24 h at 4°C. 20 200-
 
m
 
l fractions were recovered and solubilized in SDS
sample buffer.
 
Nuclear Assembly Assay
 
A condensed chromatin substrate for nuclear reassembly was prepared by
disassembling purified HeLa nuclei in mitotic cytosol as described previ-
ously (Collas et al., 1999). Condensed, membrane-free chromatin masses
were recovered by sedimentation through a 1 M sucrose cushion and re-
suspended in interphase cytosol at 4–5,000 chromatin U/
 
m
 
l. The cytosol
was supplemented with mitotic membranes to provide vesicles harboring
integral membrane proteins required for NE assembly (see Results) (Pyr-
pasopoulou et al., 1996). An ATP-generating system (2 mM ATP, 20 mM
creatine phosphate, 50 
 
m
 
g/ml creatine kinase) and 100 
 
m
 
M GTP were
added to promote chromatin decondensation, nuclear membrane vesicles
binding to chromatin, and fusion (Collas et al., 1996). The reaction was in-
cubated at 30
 
8
 
C for up to 2 h, and nuclear reassembly was monitored by
phase–contract microscopy, DNA staining with 0.1 
 
m
 
g/ml Hoechst 33342,
and immunofluorescence analysis of NE markers. In some experiments,
the interphase cytosol was preincubated with competitor peptides for 15
min at 4
 
8
 
C before adding the ATP-generating system.
 
Immunodepletion of AKAP149 and Reconstitution of 
Membrane Vesicles
 
Mitotic membranes (10 mg/ml protein) were solubilized with 0.5% NP-40
in MWB adjusted to 400 mM KCl (MWB/KCl) for 30 min at 4
 
8
 
C. The ex-
tract was centrifuged at 15,000
 
 g
 
 for 15 min to sediment the nonsolubilized
material. AKAP149 was immunodepleted from the clarified detergent ex-
tract using anti-AKAP149 mAbs coupled to protein A–Sepharose beads
as described below. Control immunodepletions were done using nonim-
mune mouse IgGs. AKAP149-depleted and mock-depleted vesicles were
reconstituted by dialyzing the detergent out of the unbound material
against KHM (50 mM KCl, 50 mM Hepes, pH 7.5, 4 mM MgCl
 
2
 
, 10 mM 
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EGTA, 10 mM CaCl
 
2
 
, 1 mM DTT) overnight at 4
 
8
 
C (Pyrpasopoulou et
al., 1996). After dialysis, vesicles were diluted with 1 vol of MWB, sedi-
mented at 150,000
 
 g
 
, resuspended in MWB, aliquoted, and frozen. Immu-
nodepletion of AKAP149 was verified by Western blotting analysis.
 
Immunological Procedures
 
Western blotting analysis was performed as described previously (Collas
et al., 1999) using anti-AKAP149 antibodies (1:250 dilution), anticalnexin
(1:500), anti-PP1 (1:500), and peroxidase-conjugated secondary antibod-
ies. For immunoprecipitations, whole mitotic or interphase cells were son-
icated in immunoprecipitation buffer (10 mM Tris-HCl, pH 7.5, 50 mM
KCl, 1% Triton X-100, and protease inhibitors) and the lysate was centri-
fuged at 15,000
 
 g
 
. After preclearing the supernatant, immunoprecipita-
tions were carried out with relevant antibodies (diluted 1:50) at room tem-
perature for 2.5 h, followed by incubation with protein A–Sepharose for
1 h and centrifugation at 4,000
 
 g
 
. Immune complexes were washed, and
proteins were eluted in SDS sample buffer (Collas et al., 1999). AKAP149
was immunodepleted from NP-40–solubilized mitotic vesicles as described
above. Immunofluorescence analysis of cells, nuclei, and chromatin was
performed as described earlier (Collas et al., 1999). Specimens were fixed
with 3% paraformaldehyde and permeabilized with 0.5% (cells) or 0.1%
(nuclei) Triton X-100. Alternatively and as indicated, samples were fixed
with 
 
2
 
20
 
8
 
C methanol for 5 min. Primary and secondary antibodies (FITC
or TRITC conjugated) were used at a 1:100 dilution. DNA was stained
with 0.1 
 
m
 
g/ml Hoechst 33342. Observations were made on an Olympus
BX60 microscope, and photographs were taken with a JVC camera and
AnalySIS software (Soft Imaging Systems).
 
RII and PP1 Overlays
 
AKAP149 immune precipitates were resolved by SDS-PAGE and immo-
bilized onto nitrocellulose. RII binding was detected using recombinant
 
32
 
P-labeled human RII
 
a
 
 in an overlay assay (Bregman et al., 1989). PP1
binding to immobilized AKAP149 immune precipitates was detected on a
PP1 overlay. The membrane was incubated with 0.7 U recombinant PP1
(Upstate Biotechnology) for 2 h at room temperature in TBST, washed
three times for 5 min in TBST, and PP1 binding was detected by Western
blotting using anti-PP1 mAbs.
 
Microcystin-Sepharose Affinity Purification of PP1
 
HeLa cells were harvested and lysed in immunoprecipitation buffer.
Cell lysates (250 
 
m
 
l; 4 mg total protein) were precleared with protein
A–Sepharose beads for 30 min at 4
 
8
 
C and incubated with 25 
 
m
 
l of a 50%
slurry of microcystin-Sepharose beads (Upstate Biotechnology) for 1 h at
room temperature. Beads were washed with buffer M (50 mM triethanola-
mine, pH 7.5, 0.1 mM EGTA, 5% glycerol, 0.5 M NaCl, 0.1% 
 
b
 
-mercapto-
ethanol, and protease inhibitors) to remove unbound proteins. Affinity-
purified PP1 and bound proteins were eluted with 3 M NaSCN in buffer
M. Input lysate, unbound fractions, and bound eluates were subjected to
immunoblotting analysis. Control samples were incubated with protein
A–Sepharose beads and processed as above. PP1 was also affinity-purified
from purified NEs (5–10 
 
3 
 
10
 
7
 
) solubilized with 1% Triton X-100/1 M
NaCl.
Figure 1. AKAP149 is a protein of the ER/NE network. (A) RII overlay of HeLa cell NE proteins using 32P-labeled RIIa as a probe
without or with 100 nM Ht31 competitor peptide (left). Asterisks indicate RII-binding proteins; arrowhead points to RII. The filters
were also immunoblotted using anti-AKAP95 and anti-AKAP149 mAbs (right). (B) Structural domains of AKAP149. TM, predicted
transmembrane domain. KGVLF represents a putative PP1-binding domain. AKAP49 also contains PKA-RII–binding and putative
RNA-binding (KH) domains. aa, amino acids. (C) Distribution of AKAP149 in unsynchronized HeLa cells was examined by immuno-
fluorescence using the anti-AKAP149 mAb. (D) Interphase and mitotic HeLa cells were fractionated into nuclei or chromatin, cytosol,
and cytoplasmic membranes and each fraction was immunoblotted using anti-AKAP149 mAbs. (E) Interphase membrane vesicles were
fractionated by floatation in a sucrose density gradient, and fractions were immunoblotted using anticalnexin and anti-AKAP149 anti-
bodies. P, residual pellet. Bar, 10 mm. 
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Results
 
AKAP149 Is an Integral Membrane Protein of the ER 
and of the NE
 
In a search for AKAPs of the NE, we performed an overlay
of immobilized purified HeLa NE proteins with 
 
32
 
P-labeled
recombinant human RII
 
a
 
. In addition to PKA-RII
 
a
 
 (Fig.
1 A, arrowhead), three PKA-binding proteins of apparent
 
M
 
r 
 
z 
 
150, 
 
z 
 
130, and 95 kD were identified (Fig. 1 A, as-
terisks). RII
 
a
 
 binding to each protein was competed with
100 nM of the AKAP-RII anchoring inhibitor peptide
Ht31 (Carr et al., 1991), illustrating the specificity of bind-
ing. Probing the membrane with an anti-AKAP95 mAb
argued that the 95-kD RII-binding protein was AKAP95
(Fig. 1 A, blot), an AKAP of the nuclear matrix and thus
expected in our NE preparations. Moreover, the 
 
z
 
150-kD
protein comigrated with AKAP149 when the membrane
was probed with an anti-AKAP149 mAb (Fig. 1 A), sug-
gesting that this RII-binding protein was AKAP149. Note
that an 80-kD RII-binding polypeptide faintly detected in
the overlay comigrated with a peptide detected by anti-
AKAP149 mAbs, suggesting that this peptide was a pro-
teolytic product of AKAP149 (Fig. 1 A). The 
 
z
 
130-kD
polypeptide remains unaccounted for to date.
Sequence analysis of AKAP149 revealed that the pro-
tein contains one NH
 
2
 
-terminal transmembrane domain
(Fig. 1 B; TM at residues 6–28). This is highly consistent
with the functional transmembrane domain identified in
the AKAP149 splice variants (Lin et al., 1995); Chen et al.,
1997; Huang et al., 1997). A PKA type II (RII) anchoring
domain and a putative RNA-binding (KH) domain have also
been identified (Trendelenburg et al., 1996). AKAP149
also harbors a putative consensus binding site for PP1
(K
 
153
 
GVLF
 
157
 
) (Zhao and Lee, 1997) (Fig. 1 B). These ob-
servations suggest that AKAP149 is a transmembrane pro-
tein with multiple functional domains.
We examined the subcellular localization of AKAP149
in HeLa cells using the anti-AKAP149 mAb (note that
AKAP149 was also detected on immunoblots of human B
cell, T cell, epithelial and endothelial cell lines; data not
shown). Immunofluorescence analysis of methanol-fixed
HeLa cells showed that AKAP149 was primarily cyto-
plasmic and that the mAbs also decorated the nuclear
periphery (Fig. 1 C). Similar results were obtained with
paraformaldehyde-fixed cells (data not shown). Further-
more, AKAP149 cofractionated with nuclei and cytoplas-
mic membranes of interphase cells, and with membranes
of mitotic cells (Fig. 1 D). Additionally, when interphase
microsomes were fractionated by floatation to density
equilibrium in a sucrose gradient, AKAP149 was found to
cofractionate with calnexin, a marker of the ER mem-
brane (Fig. 1 E). These results indicate that AKAP149 is a
protein of the ER membrane network, and as the outer
nuclear membrane is continuous with the ER, detection of
AKAP149 in nuclei argues that the AKAP also resides in
the NE.
The subnuclear localization of AKAP149 was identified
in purified HeLa nuclei fractionated into chromatin, “ma-
trix” (defined as a detergent-, high salt–, and DNase-resis-
tant nuclear extract), and NE (nuclear membrane/lamina
fraction). AKAP149 was detected exclusively in the NE by
 
immunoblotting (Fig. 2 A). NE localization of AKAP149
was confirmed by immunofluorescence analysis of purified
nuclei, as shown by colocalization with LBR and lamin B,
markers of the inner nuclear membrane and of the nuclear
lamina, respectively (Worman et al., 1990) (Fig. 2 B). Ad-
ditionally, AKAP149 was not extractable from purified
NEs with 1 M NaCl or alkaline treatment, but was
partially extracted with 1% Triton X-100 and fully ex-
tracted with 1% Triton X-100/1 M NaCl (Fig. 2 C). Thus,
Figure 2. AKAP149 is an integral membrane protein of the NE.
(A) Purified HeLa nuclei were fractionated into chromatin, ma-
trices, and NEs and distribution of AKAP149 in each fraction
was determined by immunoblotting. (B) Immunofluorescence
colocalization of AKAP149 with either LBR (top) or lamin B
(bottom) in isolated HeLa nuclei. DNA was labeled with Hoechst
33342. (C) Purified HeLa NEs were extracted with 1% Triton
X-100, 1 M NaCl, 1% Triton X-100/1 M NaCl, or 1 N NaOH. Un-
extracted (P) and extracted proteins (S) were immunoblotted us-
ing anti-AKAP149 mAb. (D) Purified HeLa cell microsomes (In-
put mic.) were exposed to either no trypsin, 100 mg/ml trypsin, or
100  mg/ml trypsin plus 100 mg/ml soybean trypsin inhibitor
(SBTI), for 15 min and solubilized in SDS sample buffer. Acces-
sibility of AKAP149 and of the ER protein calnexin to trypsin
was analyzed by immunoblotting. Bars, 10 mm. 
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AKAP149 exhibits extraction properties of integral mem-
brane proteins, supporting the topology of AKAP149 pre-
dicted by its primary structure. We concluded that in ad-
dition to being distributed in the ER, AKAP149 is an
integral protein of the NE.
The topology of AKAP149 in the ER/NE membrane was
determined by assessing the sensitivity of the AKAP149
epitope (localized between amino acids 66 and 212) to
trypsin digestion. Immunoblotting analysis shows that
treatment of intact microsomes with 100 
 
m
 
g/ml trypsin
fully degraded AKAP149, whereas calnexin (whose
epitope faces the ER lumen) was not affected (Fig. 2 D).
This result indicates that the bulk of AKAP149 faces the
cytoplasm.
 
AKAP149 Binds PP1 In Vitro and In Vivo
 
We have identified a putative binding site for PP1 in the
NH
 
2
 
-terminal domain of AKAP49 (see Fig. 1 A). To test
whether AKAP149 interacts with PP1, we first determined
whether AKAP149 bound PP1 in an overlay assay. An
AKAP149 immune precipitate from HeLa cell lysates was
immobilized onto nitrocellulose, incubated with recombi-
nant PP1, and PP1 binding was detected by immunoblot-
ting. Fig. 3 A shows that PP1 bound to a 149-kD protein of
the AKAP149 immune complex, but not to a control pre-
cipitate. PP1 binding was abolished by 10 
 
m
 
M of a compet-
itor peptide containing the putative PP1-binding site of
AKAP149 (PP1-BD: SSPKGVLFSS). However, binding
was not inhibited by 10 
 
m
 
M of a control PP1-BD(V155A)
peptide harboring a Val
 
155
 
®
 
Ala mutation, or by 10 
 
m
 
M of
the RII-anchoring inhibitor peptide Ht31 (Fig. 3 A). As
the Val
 
®
 
Ala mutation within the PP1-binding domain of
PP1 regulatory subunits is known to abolish interaction
with PP1 (Beullens et al., 1999), we concluded from these
data that AKAP149 bound PP1 in vitro.
Interaction of AKAP149 with PP1 in vivo was examined
in affinity purification and immunoprecipitation experi-
ments. Affinity purification of PP1 from interphase cell
lysates with the PP1 inhibitor microcystin, coupled to
sepharose beads, copurified AKAP149 as shown by immu-
noblotting of microcystin-Sepharose–bound and unbound
fractions (Fig. 3 B). In contrast, neither protein was iso-
lated with control protein A–Sepharose beads (Fig. 3 B).
Thus, AKAP149 resides in a complex with PP1 in vivo. To
determine whether NE-associated AKAP149 was also as-
sociated with PP1, we carried out immunoprecipitations
from NE extracts. Immunoblotting analysis of nuclei and
purified NEs revealed PP1 in these structures (Fig. 3 C,
left). Moreover, AKAP149 and PP1 were coimmunopre-
cipitated from NE extracts using either anti-AKAP149 or
anti-PP1 mAbs (Fig. 3 C, right). These results argue that
AKAP149 is associated with PP1 in vivo and may anchor
PP1 at the NE.
 
Dynamics of Nuclear Membranes, Lamin B, and PP1 
during Nuclear Reconstitution In Vitro
 
To investigate the dynamics of the interaction of
AKAP149 with PP1 at the NE, we developed a cell-free
assay that recapitulates nuclear reassembly at the end of
mitosis. A condensed chromatin substrate was prepared
by disassembling purified HeLa nuclei in a mitotic cytosol
(Steen et al., 2000). The condensed chromatin was purified
through a sucrose cushion and resuspended in interphase
cytosol containing an ATP-regenerating system and exog-
enous membrane vesicles to promote nuclear assembly.
The distribution of PP1 and AKAP149 was monitored
by immunofluorescence during successive stages of nu-
clear reassembly. As the chromatin decondensed, mem-
brane vesicles were targeted to the chromatin and fused to
form nuclear membranes, as shown by phase–contrast and
immunofluorescence analysis of the LBR (Fig. 4 A). Nu-
cleoli were also detected in reconstituted nuclei (Fig. 4 A,
120 min), indicating that nuclear import and nucleolus as-
sembly were also recapitulated in the extract. PP1 was as-
sociated with input condensed chromosomes (Fig. 4 A,
PP1, 0 min) in agreement with earlier observations of mi-
totic cells (Fernandez et al., 1992). As the chromatin de-
condensed, PP1 labeling faded (30 min) and sealing of nu-
Figure 3. AKAP149 binds PP1 in vitro and in vivo. (A) Binding
of PP1 to AKAP149. AKAP149 and control immune precipitates
(IP) immobilized on nitrocellulose (AKAP149 blot) were incu-
bated with either recombinant PP1 alone, PP1 plus 10 mM com-
petitor peptide PP1-BD, PP1 plus 10 mM control PP1-
BD(V155A) peptide, or PP1 plus 10 mM RII-anchoring inhibitor
peptide Ht31. PP1 binding was detected by immunoblotting using
the anti-PP1 mAb. (B) Affinity purification of PP1 with micro-
cystin-sepharose beads from interphase cell lysates. Immunoblot
analysis was carried out on input lysate (Input), microcystin-
treated lysate (Unbound), and eluates from microcystin-
sepharose beads (Bound) using anti-PP1 and anti-AKAP149
mAbs. Control isolations were performed with protein A–Seph-
arose beads. (C) Left panel, immunoblot of nuclei and NEs with
anti-PP1 mAb. Right panels, AKAP149 and PP1 were immuno-
precipitated (IP) from NE extracts and precipitates were immu-
noblotted using anti-PP1 and anti-AKAP149 mAbs. IgG, control
immunoprecipitation with nonimmune mouse IgGs. 
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clear membranes by 60 min coincided with smooth
peripheral staining of PP1, suggesting a recruitment of at
least some PP1 to the NE. Labeling of PP1 at the NE coin-
cided with assembly of lamin B into the NE (Fig. 4 A).
Moreover, colabeling of PP1 and AKAP149 showed that
recruitment of PP1 to the NE correlated with assembly of
AKAP149 into the NE (Fig. 4 B). Altogether, these obser-
vations illustrate the redistribution of a fraction of chro-
matin-associated PP1 to the NE. They also illustrate a
temporal relationship between PP1 recruitment to the NE
and AKAP149 assembly into nuclear membranes.
A consistent observation in the above experiment was
the fading of intranuclear PP1 labeling during chromatin
decondensation and its absence from the nuclear interior
in reconstituted nuclei (Fig. 4). Western blotting analysis
of equal numbers (10
 
5
 
) of purified interphase HeLa nuclei,
chromatin masses condensed in vitro, and nuclei reconsti-
tuted in vitro using the anti-PP1 mAb revealed similar
amounts of PP1 in all samples (data not shown). Thus, the
disappearance of intranuclear PP1 labeling during nuclear
reassembly in vitro resulted from antigen masking rather
than from solubilization of the phosphatase.
 
AKAP149 Recruits PP1 at the NE upon Nuclear 
Assembly In Vitro
 
Interaction of PP1 with AKAP149 and localization of PP1
at the nuclear periphery during nuclear reassembly in vitro
led to the hypothesis that NE-bound AKAP149 recruits
PP1 during nuclear reassembly. To test this, nuclei were
reassembled in vitro as above except that the interphase
cytosol contained 1 
 
m
 
M of the PP1 binding competitor
peptide PP1-BD, or 1 
 
m
 
M of the control PP1-BD(V155A)
peptide. Either peptide was preincubated with condensed
chromatin on ice for 15 min before induction of nuclear
reassembly. After 2 h at 30
 
8
 
C, AKAP149 and PP1 were
immunofluorescently examined after methanol fixation.
Both control cytosols (containing no peptide or PP1-
BD[V155A]) and PP1-BD–containing cytosol promoted
assembly of nuclear membranes harboring AKAP149
(Fig. 5 A). However, PP1-BD, but not PP1-BD(V155A),
completely abolished PP1 labeling at the nuclear periph-
ery (Fig. 5 A). This was verified with the anti-PP1 mAb
(see below, in Fig. 7 A). Therefore, binding of PP1 to
AKAP149 is implicated in recruiting of PP1 to the NE.
To provide further evidence for the role of AKAP149 in
PP1 recruitment to the NE, we reassembled nuclei using
membrane vesicles depleted of AKAP149. AKAP149 was
immunodepleted (or mock-depleted) from mitotic mem-
brane vesicles after solubilization with 0.5% NP40/0.4 M
KCl, by two rounds of immunoprecipitation using the anti-
AKAP149 mAb. Solubilized vesicles were reconstituted af-
ter detergent removal by dialysis, vesicles were sedimented
and washed, and AKAP149 depletion was assessed on
Western blots. AKAP149 was clearly immunodepleted from
the vesicles, whereas mock depletions using nonimmune
mouse IgGs did not remove the AKAP (Fig. 5 B). Both
mock-depleted and immunodepleted reconstituted vesi-
cles were used in nuclear reassembly assays.
Nuclei reassembled in vitro from mock- or AKAP149-
depleted vesicles were morphologically indistinguishable
by phase–contract microscopy (Fig. 5 C). Both sets of
nuclei contained nuclear membranes (Fig. 5 C, Phase),
indicating that depletion of AKAP149 from NE-precursor
vesicles did not hinder the assembly of these structures,
and that integral membrane proteins required for NE as-
sembly were successfully reconstituted. However, AKAP149
was not detected by immunofluorescence analysis of nu-
clei reassembled from AKAP149-depleted vesicles (Fig. 5
C). More importantly, PP1 was undetectable in these nu-
clei but was clearly localized at the NE of nuclei reas-
sembled from mock-depleted control vesicles (Fig. 5 C).
AKAP149 and PP1 were also detected in the NE of nuclei
reformed from solubilized and reconstituted control vesi-
cles not exposed to immunoglobulins (data not shown).
We concluded that the absence of AKAP149 from nuclear
membranes abolished the targeting of PP1 to the NE upon
nuclear reassembly.
Figure 4. Recruitment of nuclear PP1 to the NE upon nuclear re-
assembly in vitro. Condensed chromatin substrates were incu-
bated in an interphase extract containing membrane vesicles. (A)
Nuclear reassembly was monitored by phase–contrast micros-
copy (top). DNA was stained with Hoechst 33342. Assembly of
nuclear membranes and PP1 distribution were examined by im-
munofluorescence analysis of methanol-fixed nuclei, using anti-
LBR rabbit polyclonal antibodies and anti-PP1 mAbs, respec-
tively. Nuclear lamina assembly was visualized using anti-lamin B
antibodies. (B) PP1 distribution and targeting of AKAP149 to
the reforming nucleus were monitored by double immunofluo-
rescence using anti-PP1 polyclonal antibodies and the anti-
AKAP149 mAb. Note the association of PP1 with the nuclear pe-
riphery only when AKAP149 is assembled into the NE (z60
min). Bars, 10 mm. 
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To definitely establish the role of NE-bound AKAP149
in recruiting PP1, we performed a rescue experiment
allowing the reincorporation of AKAP149 into nuclear
membranes. To this end, nuclei assembled with AKAP149-
depleted vesicles were sedimented through a sucrose cush-
ion and resuspended in fresh interphase cytosol. Exoge-
nous PP1 was provided to the cytosol with recombinant
PP1 (7 
 
3 
 
10
 
2
 
3
 
 U/
 
m
 
l cytosol) to ensure that PP1 was not
limiting. The cytosol contained either no exogenous vesi-
cles, AKAP149-depleted vesicles (control), or mock-depleted
vesicles harboring AKAP149. GTP was added to all ex-
tracts to promote vesicle fusion with existing nuclear
membranes (Collas et al., 1996). The results are shown in
Fig. 6. Without exogenous vesicles, or with AKAP149-
depleted vesicles, no AKAP149 staining was detected and
faint intranuclear PP1 labeling occurred. However, in cyto-
sol harboring AKAP149-containing membranes, AKAP149
was clearly detected in the NE (no such staining occurred
when GTP was omitted from the cytosol, indicating that
AKAP149 was incorporated into the NE as a result of
membrane fusion; data not shown). Furthermore, PP1 was
exclusively detected at the NE where it colocalized with
AKAP149. Importantly, NE targeting of PP1 was in-
hibited with 10 
 
m
 
M PP1-BD and thus was mediated by
AKAP149. Collectively, these results indicate that incor-
poration of AKAP149 into AKAP149-deficient nuclear
membranes restores targeting of PP1 to the NE, and dem-
 
onstrate that AKAP149 anchors PP1 to the NE upon nu-
clear reassembly in the extract.
 
Recruitment of PP1 to the NE Correlates with
Lamin B Assembly
 
Reassembly of the nuclear lamina at the end of mitosis re-
quires lamin dephosphorylation. Inhibition experiments,
cofractionation of the lamin phosphatase activity and PP1,
and affinity copurification of PP1 and lamin B phos-
phatase activity with microcystin-sepharose beads have
previously pointed to PP1 as a mitotic lamin B phos-
phatase (Thompson et al., 1997). Additionally, we showed
that lamin B assembly correlated with assembly of
AKAP149 and recruitment of PP1 to the NE (see Fig. 4).
These observations raise the hypothesis that targeting of
PP1 to the NE is a prerequisite for the assembly of the nu-
clear lamina.
To address this issue, we examined by immunofluores-
cence the relationship between PP1 targeting to the NE
and lamin B assembly into the NE in the course of three
experiments performed earlier. The results are shown in
Fig. 7. First, lamin B assembly was examined during
nuclear assembly without any competitor peptide, with
PP1-BD, or with the control PP1-BD(V155A) peptide. As
shown earlier with the anti-PP1 polyclonal antibody (see
Fig. 5 A), only PP1-BD abolished PP1 recruitment to the
Figure 5. AKAP149 anchors nu-
clear PP1 at the NE. (A) Inhibi-
tion of PP1 recruitment to the
NE by PP1-BD. Nuclei were re-
assembled in vitro as in the leg-
end to Fig. 4; however, the inter-
phase cytosol was preincubated
with either no peptide, 10 mM of
the PP1-binding competitor pep-
tide PP1-BD, or 10 mM of con-
trol peptide PP1-BD(V155A).
An ATP-generating system was
added to promote nuclear reas-
sembly at 308C. After 2 h, the
NE distribution of AKAP149
and PP1 was examined by
phase–contrast and by immuno-
fluorescence analysis using the
anti-AKAP149 mAb and anti-
PP1 polyclonal antibodies. (B)
Immunodepletion of AKAP149
from mitotic membrane vesi-
cles. Mitotic vesicles were solu-
bilized with 0.5% NP-40/0.4 M
KCl, and AKAP149 was immu-
nodepleted by two successive
rounds of immunoprecipitation.
Mock depletions were per-
formed with nonimmune mouse
IgGs. AKAP149-depleted and
mock-depleted vesicles were reconstituted by dialysis, washed, and aliquots were dissolved in SDS sample buffer. AKAP149 immu-
nodepletion was monitored by immunoblotting each fraction. (C) PP1 is not recruited to AKAP149-depleted NEs. Nuclei were reas-
sembled in interphase cytosol using membrane vesicles either mock-depleted (left) or immunodepleted of AKAP149 (right). Distribu-
tion of AKAP149 and PP1 was determined by immunofluorescence. Bars, 10 mm. 
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NE (Fig. 7 A). Remarkably, lamin B also remained unde-
tected with PP1-BD, while its assembly occurred normally
in control nuclei (Fig. 7 A). Second, nuclei reconstituted in
vitro with AKAP149-depleted vesicles (see Fig. 5 C) did
not harbor any detectable lamin B (nor PP1), whereas nu-
clei reassembled from mock-depleted vesicles clearly in-
corporated lamin B (Fig. 7 B). Third, in a rescue experi-
ment involving restitution of AKAP149 into AKAP149-
depleted nuclear membranes (see Fig. 6), restoration of
PP1 targeting to the NE also restored lamin B assembly (Fig.
7 C). In contrast, absence of NE-associated AKAP149,
and thereby of PP1, or inhibition of PP1 recruitment to the
NE by PP1-BD both abolished lamin B assembly (Fig. 7
C). It is noteworthy that the detection of nucleoli in nuclei
Figure 6. Restitution of AKAP149 in nuclear
membranes restores recruitment of exoge-
nous PP1 to the NE. Nuclei reconstituted with
AKAP149-depleted vesicles as in Fig. 5 C
were sedimented through sucrose and resus-
pended into fresh interphase cytosol contain-
ing combinations of recombinant PP1,
AKAP149-depleted vesicles (control), mock-
depleted vesicles (harboring AKAP149), and
10 mM of the PP1-binding competitor peptide
PP1-BD. GTP was added to all reactions to
promote fusion of vesicles with nuclear mem-
branes. After 1.5 h, distribution of AKAP149
and PP1 was examined by immunofluores-
cence. Bar, 10 mm.
Figure 7. Targeting of PP1 to
the NE by AKAP149 correlates
with lamin B assembly. (A) PP1-
BD prevents lamin B assembly.
Nuclei were reassembled in the
absence of competitor peptide,
or with 10 mM PP1-BD or con-
trol PP1-BD(V155A), as in Fig.
5 A. Targeting of PP1 to the NE
and assembly of lamin B were
analyzed by immunofluores-
cence. (B) AKAP149-depleted
nuclei do not assemble lamin B.
Nuclei were reassembled from
mock-depleted or AKAP149-
depleted vesicles as in Fig. 5 B,
and targeting of PP1 and lamin B
to the NE was monitored by im-
munofluorescence as in A. (C)
Restitution of AKAP149 in the
NE restores lamin B assembly.
Nuclei reformed from AKAP149-
depleted vesicles as in B were
exposed to fresh interphase cyto-
sol containing combinations of
PP1, AKAP149-depleted vesi-
cles, mock-depleted vesicles, and
PP1-BD as in the legend to Fig. 6.
After 1.5 h, PP1 targeting to the
NE and lamin B assembly were
immunofluorescently examined.
Insets, DNA staining with
Hoechst  33342. Bars, 10 mm. 
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assembled in the presence of PP1-BD or from AKAP149-
depleted vesicles (see Fig. 5) indicates that nuclear import
did occur, ruling out the possibility that the absence of
lamin B detection in these nuclei was a mere consequence
of defective nuclear import. Rather, our results indicate
that PP1 targeting to the NE by AKAP149 correlates with
polymerization of B-type lamins into the lamina.
 
Discussion
 
We report a role of the PKA-binding protein AKAP149 as
a targeting and anchoring protein for PP1 at the NE upon
somatic nuclear reassembly in vitro.We also demonstrate a
requirement of PP1 targeting to the NE for assembly of
the nuclear lamina. Targeting of PP1 by AKAP149 sup-
ports a concept whereby AKAPs may constitute molecu-
lar platforms anchoring entire signaling units rather than
PKA alone. This adds to the previous demonstration of
subcellular targeting of PKA and/or PKC together with
PP1 or PP2B by AKAP79 (Coghlan et al., 1995; Klauck et
al., 1996), AKAP220 (Schillace and Scott, 1999), and yo-
tiao/AKAP450/CG-NAP (Takahashi et al., 1999; West-
phal et al., 1999; Witczak et al., 1999).
 
AKAP149 Is an Integral Membrane Protein of the NE
 
We identified AKAP149 as an integral protein of the ER
and NE membranes, with a NH
 
2
 
-terminal transmembrane
domain and the bulk of the protein facing the cytoplasm.
Recruitment of chromatin-bound PP1 to the NE by
AKAP149 argues that AKAP149 is also anchored in the
inner nuclear membrane. This is consistent our obser-
vation that A/C-type lamins coimmunoprecipitate with
AKAP149 from solubilized NE preparations (Steen, R.L.,
and P. Collas, unpublished data). To our knowledge, this
makes AKAP149 the first example of a cellular integral
protein localized in both nuclear membranes rather than
being restricted to either membrane domain (see Worman
and Courvalin, 2000). Sequence information and topology
studies suggest that the cytoplasmic or nucleoplasmic do-
main of AKAP149 approximates 147 kD, which by far ex-
ceeds the size limit allowing the diffusion of membrane
proteins through the nuclear pore complex (Soullam and
Worman, 1995). Thus, it is unlikely that AKAP149 dif-
fuses from the ER to the inner nuclear membrane during
interphase. Rather, a portion of ER-bound AKAP149
may become restricted to the inner nuclear membrane
upon targeting to chromatin when nuclear membranes re-
form at the end of mitosis, while the rest of AKAP149 re-
mains in the ER/outer nuclear membrane network.
 
Anchoring of PP1 at the NE by a PKA-binding Protein
 
Two major nuclear regulatory subunits of PP1 have previ-
ously been identified, nuclear inhibitory subunit of PP1
(NIPP1) (Jagiello et al., 1995) and PP1 nuclear targeting
subunit (PNUTS) (Allen et al., 1998), which have been
proposed to target PP1 to RNA (Jagiello et al., 1997).
AKAP149 also binds PP1 in vitro and in vivo and harbors
a KGVLF domain in its NH
 
2
 
-terminal domain, which falls
within known PP1-binding consensus motifs (Zhao and
Lee, 1997). Based on these criteria, we propose that
AKAP149 constitutes a novel PP1 targeting protein. How-
ever, whether AKAP149 also acts as a regulatory subunit
of PP1 remains undetermined. Affinity purification and
coimmunoprecipitation experiments have identified NIPP1
in the AKAP149–PP1 complex in vivo (Steen, R.L., and P.
Collas, unpublished data). This suggests that AKAP149
functions as a targeting protein for the PP1–NPP1 holoen-
zyme, with no regulatory activity. Alternatively, in addition
to its targeting role, AKAP149 may regulate PP1 activity
together with NIPP1 (synergistically or antagonistically) at
the level of the NE. These hypotheses remain to be tested.
Remarkably, the KGVLF domain of AKAP149 is flanked
by four serines, raising the possibility that their phos-
phorylation by a Ser/Thr kinase regulates AKAP149–PP1
interaction. To support this view, phosphorylation of serines
flanking the RV
 
X
 
F motif of NIPP1 by PKA and casein ki-
nase 2 affects the association of PP1 with NIPP1 (Beullens
et al., 1993). Furthermore, PKA-mediated phosphoryla-
tion of the PP1 regulatory subunit GM, which targets PP1
to glycogen in skeletal muscle, also abolishes PP1 binding
(Egloff et al., 1997). Thus, phosphorylation of PP1 regula-
tory subunits may modulate PP1 activity by altering its
binding to the regulatory subunit.
We have shown that NE-associated AKAP149 not only
anchors PP1 but also binds PKA in vitro. We cannot at
present ascertain whether AKAP149 anchors PKA and
PP1 in distinct complexes or in a single ternary complex,
but in either situation, implications of a PKA-binding pro-
tein anchoring a phosphatase at the NE are several. First,
AKAP149 may conceivably position PKA and PP1 in
close proximity where they can reversibly modulate the
phosphorylation of nuclear substrates such as NPP1 (Beul-
lens et al., 1993), DNA-binding cAMP response elements
(Riabowol et al., 1988), B-type lamins (Peter et al., 1990),
and inner nuclear membrane proteins LBR and lamina-
associated polypeptides, which all harbor PKA phos-
phorylation sites. Phosphorylation/dephosphorylation of
B-type lamins in interphase (Kill and Hutchison, 1995)
may be implicated in the regulation of NE–chromatin in-
teractions, which in turn may regulate intranuclear pro-
cesses such as replication of heterochromatin or re-
distribution of B-type lamins from the NE to foci of DNA
replication (Ellis et al., 1997). Second, as no PKA regula-
tory subunit has been detected in the nucleus (Eide et al.,
1998), AKAP149 may also target the PKA holoenzyme at
the NE (presumably on the cytoplasmic face of the outer
nuclear membrane) to enhance the efficiency of transloca-
tion of activated PKA catalytic subunits to the nucleus in re-
sponse to cAMP signaling (Riabowol et al., 1988). Finally,
PKA may constitute a regulator of AKAP149–PP1 binding
by altering AKAP149 phosphorylation. Indeed, association
of AKAP149 with PP1 is cell cycle regulated, as AKAP149
remains associated with ER membranes at mitosis (Fig. 1)
while PP1 is bound to chromatin (Fernandez et al., 1992).
AKAP149 and NE-associated PP1 Are Implicated in 
Nuclear Lamina Assembly
Our observations suggest that NE-associated PP1 pro-
motes lamina assembly at the end of mitosis. PP1 has been
shown to be the major lamin B phosphatase at mitosis exit
(Thompson et al., 1997), such that NE-associated PP1 may
dephosphorylate B-type lamins before their assembly intoThe Journal of Cell Biology, Volume 150, 2000 1260
the lamina. Consistent with this view is our observation
that targeting of PP1 to the NE by AKAP149 upon nu-
clear reformation correlates with lamin B assembly. Phos-
phorylation of avian lamin B2 by PKC has been shown to
impair nuclear import of the lamin (Hennekes et al., 1993).
If this holds true in mammals, dephosphorylation of PKC
sites by an as yet unidentified cytoplasmic phosphatase
should precede nuclear import of B-type lamins. PP1
anchored at the nuclear membrane may subsequently
dephosphorylate additional (non-PKC) residues after nu-
clear import of the lamins, albeit before their poly-
merization into a lamina.
In addition to providing structural support to the nu-
cleus, lamins have been proposed to assume a variety of
nuclear functions (Ellis et al., 1997; Jagatheesan et al.,
1999). Most significantly, two hereditary disorders, Em-
ery-Dreifuss muscular dystrophy and a lipodystrophy
(Dunningan’s disease), have been shown to correlate with
mutations in the Lmna (lamin A/C) gene (Bonne et al.,
1999; Cao and Hegele, 2000), and Lmna2/2 mice develop a
pathology analogous to Emery-Dreifuss muscular dystro-
phy (Sullivan et al., 1999). Interestingly, the nuclei of
Lmna2/2 mice are deformed and exclude B-type lamins
specifically in the deformed areas (Sullivan et al., 1999).
This suggests that interactions between B-type lamins
and the inner nuclear membrane or chromatin, or the po-
lymerization state of lamin B, are altered in these regions.
It will be relevant to examine the mechanism underlying
B-type lamin distribution in affected nuclei and whether
AKAP149 is implicated in the mislocalization of these
lamins.
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